Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.

Psychometric Evaluation of the Hypogonadism Impact of Symptoms Questionnaire.

Gelhorn HL, Dashiell-Aje E, Miller MG, DeRogatis LR, Dobs A, Seftel AD, Althof SE, Brod M, Revicki DA.

J Sex Med. 2016 Nov;13(11):1737-1749. doi: 10.1016/j.jsxm.2016.09.006. Epub 2016 Sep 28.

2.

Psychometric Evaluation of the Hypogonadism Impact of Symptoms Questionnaire Short Form (HIS-Q-SF).

Gelhorn HL, Roberts LJ, Khandelwal N, Revicki DA, DeRogatis LR, Dobs A, Hepp Z, Miller MG.

J Sex Med. 2017 Aug;14(8):1046-1058. doi: 10.1016/j.jsxm.2017.05.013.

PMID:
28760247
3.

Development of the Hypogonadism Impact of Symptoms Questionnaire Short Form: Qualitative Research.

Gelhorn HL, Bodhani AR, Wahala LS, Sexton C, Landrian A, Miller MG, Derogatis L, Dobs A, Revicki DA.

J Sex Med. 2016 Nov;13(11):1729-1736. doi: 10.1016/j.jsxm.2016.09.007. Epub 2016 Oct 4.

4.

Content Validity of the Hypogonadism Impact of Symptoms Questionnaire (HIS-Q): A Patient-Reported Outcome Measure to Evaluate Symptoms of Hypogonadism.

Gelhorn HL, Vernon MK, Stewart KD, Miller MG, Brod M, Althof SE, DeRogatis LR, Dobs A, Seftel AD, Revicki DA.

Patient. 2016 Apr;9(2):181-90. doi: 10.1007/s40271-015-0138-8.

PMID:
26334870
5.

Psychometric validation of a sexual quality of life questionnaire for use in men with premature ejaculation or erectile dysfunction.

Abraham L, Symonds T, Morris MF.

J Sex Med. 2008 Mar;5(3):595-601. doi: 10.1111/j.1743-6109.2007.00749.x. Epub 2008 Jan 18.

PMID:
18208501
6.

Demographic and Clinical Correlates of Patient-Reported Improvement in Sex Drive, Erectile Function, and Energy With Testosterone Solution 2.

Wu F, Zitzmann M, Heiselman D, Donatucci C, Knorr J, Patel AB, Kinchen K.

J Sex Med. 2016 Aug;13(8):1212-9. doi: 10.1016/j.jsxm.2016.05.010. Epub 2016 Jun 18.

PMID:
27329542
7.

Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes.

Hackett G, Cole N, Bhartia M, Kennedy D, Raju J, Wilkinson P.

J Sex Med. 2013 Jun;10(6):1612-27. doi: 10.1111/jsm.12146. Epub 2013 Apr 3.

PMID:
23551886
8.

The reliability, validity, and preliminary responsiveness of the Eye Allergy Patient Impact Questionnaire (EAPIQ).

Alexander M, Berger W, Buchholz P, Walt J, Burk C, Lee J, Arbuckle R, Abetz L.

Health Qual Life Outcomes. 2005 Oct 31;3:67.

9.

Psychometric testing of two new patient-reported outcome instruments for the evaluation of treatment for hypogonadism.

Hayes RP, Ni X, Heiselman DE, Kinchen K.

Int J Clin Pract. 2016 Jul;70(7):587-95. doi: 10.1111/ijcp.12828. Epub 2016 Jun 13.

10.

Sleep disturbance as a clinical sign for severe hypogonadism: efficacy of testosterone replacement therapy on sleep disturbance among hypogonadal men without obstructive sleep apnea.

Shigehara K, Konaka H, Sugimoto K, Nohara T, Izumi K, Kadono Y, Namiki M, Mizokami A.

Aging Male. 2018 Jun;21(2):99-105. doi: 10.1080/13685538.2017.1378320. Epub 2017 Sep 18.

PMID:
28920756
11.
12.

Further psychometric validation of the sexual life quality questionnaire for men with erectile dysfunction and their partners on a modified Spanish language version.

Gutiérrez P, Hernández P, Sanz E, Cardeñosa O, Mas M.

J Sex Med. 2009 Oct;6(10):2698-706. doi: 10.1111/j.1743-6109.2009.01315.x. Epub 2009 May 7.

PMID:
19453884
13.

A menopause-specific quality of life questionnaire: development and psychometric properties.

Hilditch JR, Lewis J, Peter A, van Maris B, Ross A, Franssen E, Guyatt GH, Norton PG, Dunn E.

Maturitas. 1996 Jul;24(3):161-75. Erratum in: Maturitas 1996 Nov;25(3):231.

PMID:
8844630
14.

Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME).

Rosen RC, Wu F, Behre HM, Porst H, Meuleman EJH, Maggi M, Romero-Otero J, Martinez-Salamanca JI, Jones TH, Debruyne FMJ, Kurth KH, Hackett GI, Quinton R, Stroberg P, Reisman Y, Pescatori ES, Morales A, Bassas L, Cruz N, Cunningham GR, Wheaton OA; RHYME Investigators.

J Sex Med. 2017 Sep;14(9):1104-1115. doi: 10.1016/j.jsxm.2017.07.004. Epub 2017 Aug 7.

PMID:
28781213
15.

Evaluating the sexual experience in men: validation of the sexual experience questionnaire.

Mulhall JP, King R, Kirby M, Hvidsten K, Symonds T, Bushmakin AG, Cappelleri JC.

J Sex Med. 2008 Feb;5(2):365-76. doi: 10.1111/j.1743-6109.2007.00694.x. Epub 2007 Dec 19.

PMID:
18179460
16.

Development of a social inclusion index to capture subjective and objective life domains (Phase II): psychometric development study.

Huxley P, Evans S, Madge S, Webber M, Burchardt T, McDaid D, Knapp M.

Health Technol Assess. 2012;16(1):iii-vii, ix-xii, -1-241. doi: 10.3310/hta16010.

17.

Crosscultural Adaptation and Validation of the Korean Version of the New Knee Society Knee Scoring System.

Kim SJ, Basur MS, Park CK, Chong S, Kang YG, Kim MJ, Jeong JS, Kim TK.

Clin Orthop Relat Res. 2017 Jun;475(6):1629-1639. doi: 10.1007/s11999-017-5307-8. Epub 2017 Mar 6.

18.
19.

Improved sexual function with testosterone replacement therapy in hypogonadal men: real-world data from the Testim Registry in the United States (TRiUS).

Khera M, Bhattacharya RK, Blick G, Kushner H, Nguyen D, Miner MM.

J Sex Med. 2011 Nov;8(11):3204-13. doi: 10.1111/j.1743-6109.2011.02436.x. Epub 2011 Aug 11.

PMID:
21834870
20.

A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: psychometric testing in an open-label clinical trial.

Mathias SD, Bussel JB, George JN, McMillan R, Okano GJ, Nichol JL.

Clin Ther. 2007 May;29(5):950-962. doi: 10.1016/j.clinthera.2007.05.005.

PMID:
17697914

Supplemental Content

Support Center